Return On Equity of scPharmaceuticals Inc. from 30 Sep 2018 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
scPharmaceuticals Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Jun 2025.
  • scPharmaceuticals Inc. Return On Equity for the quarter ending 30 Jun 2025 was -2086%, a 934% decline year-over-year.
  • scPharmaceuticals Inc. annual Return On Equity for 2024 was -438%, a 350% decline from 2023.
  • scPharmaceuticals Inc. annual Return On Equity for 2023 was -97%, a 28% decline from 2022.
  • scPharmaceuticals Inc. annual Return On Equity for 2022 was -76%, a 79% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

scPharmaceuticals Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -2086% -1884% -934% 01 Apr 2025 30 Jun 2025
Q1 2025 -754% -622% -470% 01 Jan 2025 31 Mar 2025
Q4 2024 -438% -340% -350% 01 Oct 2024 31 Dec 2024
Q3 2024 -315% -238% -309% 01 Jul 2024 30 Sep 2024
Q2 2024 -202% -128% -174% 01 Apr 2024 30 Jun 2024
Q1 2024 -132% -59% -80% 01 Jan 2024 31 Mar 2024
Q4 2023 -97% -21% -28% 01 Oct 2023 31 Dec 2023
Q3 2023 -77% +2% +2.1% 01 Jul 2023 30 Sep 2023
Q2 2023 -74% -14% -23% 01 Apr 2023 30 Jun 2023
Q1 2023 -73% -25% -52% 01 Jan 2023 31 Mar 2023
Q4 2022 -76% -34% -79% 01 Oct 2022 31 Dec 2022
Q3 2022 -79% -39% -100% 01 Jul 2022 30 Sep 2022
Q2 2022 -60% -21% -53% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% -11% -29% 01 Jan 2022 31 Mar 2022
Q4 2021 -42% -3% -7.1% 01 Oct 2021 31 Dec 2021
Q3 2021 -39% +9% +18% 01 Jul 2021 30 Sep 2021
Q2 2021 -39% +10% +21% 01 Apr 2021 30 Jun 2021
Q1 2021 -37% +18% +32% 01 Jan 2021 31 Mar 2021
Q4 2020 -40% +15% +27% 01 Oct 2020 31 Dec 2020
Q3 2020 -48% -8% -19% 01 Jul 2020 30 Sep 2020
Q2 2020 -49% -13% -36% 01 Apr 2020 30 Jun 2020
Q1 2020 -55% -18% -50% 01 Jan 2020 31 Mar 2020
Q4 2019 -54% -21% -61% 01 Oct 2019 31 Dec 2019
Q3 2019 -40% -7% -21% 01 Jul 2019 30 Sep 2019
Q2 2019 -36% 01 Apr 2019 30 Jun 2019
Q1 2019 -37% 01 Jan 2019 31 Mar 2019
Q4 2018 -34% 01 Oct 2018 31 Dec 2018
Q3 2018 -33% 01 Jul 2018 30 Sep 2018

scPharmaceuticals Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -438% -340% -350% 01 Jan 2024 31 Dec 2024
2023 -97% -21% -28% 01 Jan 2023 31 Dec 2023
2022 -76% -34% -79% 01 Jan 2022 31 Dec 2022
2021 -42% -3% -7.1% 01 Jan 2021 31 Dec 2021
2020 -40% +15% +27% 01 Jan 2020 31 Dec 2020
2019 -54% -21% -61% 01 Jan 2019 31 Dec 2019
2018 -34% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.